Social media graphic advertising the AMP 2018 Pillar Workshop speaker, Helen Fernandes, PhD.

Workshop: Single-vial amplification-based NGS to interrogate variants in tumors with limited diagnostic material

Helen Fernandes, PhD, Co-director of Genomic Oncology at Columbia University, presented a talk on October 31, 2018 during the Corporate Workshop Day at the 2018 Association for Molecular Pathology (AMP) Annual Meeting in San Antonio, Texas. 

Click below to watch Dr. Fernandes’ talk:


In her talk, titled “Single-vial amplification-based NGS with rapid turn-around time for interrogation of variants in tumors with limited material”, Dr. Fernandes reviews the assays that her group at Columbia currently use and their rationale for including a customized gene panel. Dr. Fernandes then presents an overview of Pillar’s SLIMamp® technology, the ONCO/Reveal™ Multi-Cancer Panel and the PIVAT® Bioinformatics Analysis platform that her team used to test Pillar technology in their lab. Dr. Fernandes also presents performance data, specifically data on the accuracy, sensitivity and reproducibility of the validation assays. After sharing performance data on their custom Pillar panel, Dr. Fernandes shared that they will be submitting the assay for New York State approval by the end of the year.

Don’t Stop Here

More To Explore

This small academic lab ramped up in-house NGS testing despite limited resources, and you can too

“There has been sort of this push to make genomics a send-out endeavor…and we are pushing back.” Dr. Cynthia Schandl is the director of a …

Read More →

Finding flexibility in a resource limited world: Online presentation

Time and resource optimization are top-of-mind for many clinical labs working with NGS. As a resource for clinical researchers and labs, we revisit this presentation …

Read More →
Four people smile out of the screen from their lab stations.

The complexity of the NGS process, compounded by sample processing, results in unique challenges for clinical oncology laboratories

Increasingly, clinical samples of all types are being analyzed with the goal of matching patients to target therapies. In the summer of 2017, Thermo Fisher received …

Read More →
Top 5 reasons to go custom with Pillar Biosciences in graphic font

5 reasons to go custom with your next sequencing panel

Off-the-shelf next-generation sequencing (NGS) panels save on sequencing costs by targeting specific genes, and the smaller resulting datasets are easier to analyze. The catch is, …

Read More →
a graphic that reads "Garbage in, Greatness out" next to a photo of a tumor sample embedded in parafin wax for analysis

Garbage in, greatness out: making the most of FFPE samples

The cancer research community relies on formalin-fixed samples, but the quality of these samples degrades over time. Sequencing data from partially degraded samples is plagued …

Read More →
Helen Fernandes at Columbia University uses Pillar NGS panel as new tumor sequencing workhorse

Meet SLIMamp: Columbia University’s new tumor sequencing workhorse

Next generation sequencing (NGS) is a powerful diagnostic tool for identifying tumor variants. Tumor sequencing workflows often rely on off-the-shelf panels, which allow for multiplexed …

Read More →
Scroll to Top